Cargando…
Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most fatal malignancies due to its high morbidity and mortality. DNA methylation exerts a vital part in the development of PDAC. However, a mechanistic role of mutual interactions between DNA methylation and mRNA as epigenetic re...
Autores principales: | Xu, Rui, Xu, Qiuyan, Huang, Guanglei, Yin, Xinhai, Zhu, Jianguo, Peng, Yikun, Song, Jukun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949667/ https://www.ncbi.nlm.nih.gov/pubmed/31956659 http://dx.doi.org/10.1155/2019/9379864 |
Ejemplares similares
-
Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma
por: Song, Jukun, et al.
Publicado: (2018) -
Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression
por: Gao, Jun, et al.
Publicado: (2013) -
Ubiquitous Aberration in Cholesterol Metabolism across Pancreatic Ductal Adenocarcinoma
por: Gunda, Venugopal, et al.
Publicado: (2022) -
Proteome alterations in pancreatic ductal adenocarcinoma
por: Pan, Sheng, et al.
Publicado: (2020) -
Emerging Role of Epigenetic Alterations as Biomarkers and Novel Targets for Treatments in Pancreatic Ductal Adenocarcinoma
por: Roalsø, Marcus T. T., et al.
Publicado: (2022)